Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Convertible Debt (2016 - 2025)

Standard Biotools (LAB) has disclosed Convertible Debt for 12 consecutive years, with $299000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Convertible Debt changed 0.0% to $299000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $299000.0, a 0.0% change, with the full-year FY2024 number at $299000.0, down 47.45% from a year prior.
  • Convertible Debt was $299000.0 for Q3 2025 at Standard Biotools, roughly flat from $299000.0 in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $55.0 million in Q3 2023 to a low of $299000.0 in Q1 2024.
  • A 5-year average of $30.7 million and a median of $53.8 million in 2021 define the central range for Convertible Debt.
  • Peak YoY movement for Convertible Debt: soared 53.51% in 2023, then crashed 99.46% in 2024.
  • Standard Biotools' Convertible Debt stood at $54.2 million in 2021, then increased by 0.84% to $54.6 million in 2022, then crashed by 98.96% to $569000.0 in 2023, then plummeted by 47.45% to $299000.0 in 2024, then changed by 0.0% to $299000.0 in 2025.
  • Per Business Quant, the three most recent readings for LAB's Convertible Debt are $299000.0 (Q3 2025), $299000.0 (Q2 2025), and $299000.0 (Q1 2025).